WHO ICTRP trial
A Bioequivalence study of a randomized, open-label, single dose, two-way…
TCTR20250608005 · Thai Clinical Trials Registry (TCTR) · Not Recruiting
Key facts
| Trial ID | TCTR20250608005 |
|---|---|
| Public title | A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Dapagliflozin Tablet 10 mg relative to Originator Dapagliflozin Tablet 10 mg in healthy Thai volunteers under fasting condition |
| Scientific title | A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Dapagliflozin Tablet 10 mg relative to Originator Dapagliflozin Tablet 10 mg in healthy Thai volunteers under fasting condition |
| Primary sponsor | Bio-innova Co., Ltd. |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | Thailand |
| Conditions | The study is conducted in healthy Thai human volunteers to improve glycemic Bioequivalence Dapagliflozin Tablet 10 mg;Bioequivalence Dapagliflozin Tablet 10 mg |
| Interventions | The new generic products which were recently developed. Volunteer will receive a single dose of Dapagliflozin Tablet 10 mg with 240 mL of 20% w/v glucose solution in water,The marketed original products which were already available in the… |
| Registration date | Aug 6, 2025 |
| Target size | 36 |
| Secondary IDs | Nil Known |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: